Abbott Laboratories Share Price CBOE
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time
CBOE
12:22:01 22/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 102.98 USD | +0.43% |
|
+0.54% | -18.15% |
| 10:12pm | Grail rallies as FDA staff flags no major concerns for multi-cancer test | RE |
| 18/09 | Trinity Heart Experts First in the Quad Cities to Use New Afib Technology | CI |
| Market Cap | 18TCr 15TCr 15TCr 13TCr 25TCr 17,01000Cr 25TCr 1,74600Cr 67TCr 8,66500Cr 67TCr 65TCr 27,96100Cr | P/E 2026 * |
29.1x | P/E 2027 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 20TCr 18TCr 17TCr 15TCr 28TCr 19,30400Cr 28TCr 1,98200Cr 76TCr 9,83300Cr 76TCr 74TCr 31,73100Cr | EV / Sales 2026 * |
4.01x | EV / Sales 2027 * | 3.64x |
| Free-Float |
86.16% | Yield 2026 * |
2.51% | Yield 2027 * | 2.67% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
Xetra
| ABL | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
CBOE
| ABT | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Santiago S.E.
| ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 week | +0.54% | ||
| Current month | -7.13% | ||
| 1 month | -9.03% | ||
| 3 months | +15.98% | ||
| 6 months | -5.50% | ||
| Current year | -18.15% |
| 1 week | 100.39 |  | 104.37 |
| 1 month | 100.39 | | 117.34 |
| 3 years | 81.98 | | 141.08 |
| 5 years | 81.98 | | 142 |
| 10 years | 37.38 | | 142 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | +0.54% | -23.80% | +1.52% | 18TCr | |
| +0.38% | -0.08% | -24.60% | +4.12% | 18TCr | |
| -0.04% | -1.80% | -2.65% | +14.48% | 12TCr | |
| +2.41% | -2.99% | +9.58% | +71.13% | 5.89TCr | |
| -0.07% | -1.07% | -3.00% | -31.73% | 4.93TCr | |
| -0.22% | -0.37% | +10.27% | +42.75% | 4.82TCr | |
| +0.08% | +5.80% | +28.89% | +0.57% | 3.37TCr | |
| +0.22% | -2.59% | - | - | 2.78TCr | |
| +0.09% | +2.24% | +43.98% | -2.98% | 2.55TCr | |
| +1.77% | +9.57% | +9.06% | -13.10% | 2.21TCr | |
| Average | +0.52% | +1.65% | +5.30% | +9.64% | 6.23TCr | |
| Weighted average by Cap. | +0.43% | +0.95% | -8.02% | +9.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.02TCr 4.38TCr 4.12TCr 3.75TCr 7.04TCr 4,81000Cr 7.05TCr 49TCr 19TCr 2,45000Cr 19TCr 18TCr 7,90600Cr | 5.45TCr 4.75TCr 4.48TCr 4.08TCr 7.65TCr 5,22400Cr 7.66TCr 54TCr 21TCr 2,66100Cr 20TCr 20TCr 8,58700Cr |
| Net income | 630.32Cr 549.57Cr 517.61Cr 471.38Cr 883.8Cr 60TCr 884.9Cr 6.2TCr 2.39TCr 31TCr 2.37TCr 2.32TCr 99TCr | 797.76Cr 695.57Cr 655.11Cr 596.6Cr 1.12TCr 76TCr 1.12TCr 7.85TCr 3.02TCr 39TCr 3TCr 2.93TCr 1,25600Cr |
| Net Debt | 2.39TCr 2.09TCr 1.97TCr 1.79TCr 3.36TCr 2,29300Cr 3.36TCr 24TCr 9.07TCr 1,16800Cr 8.99TCr 8.79TCr 3,77000Cr | 2.1TCr 1.83TCr 1.72TCr 1.57TCr 2.94TCr 2,00800Cr 2.94TCr 21TCr 7.94TCr 1,02300Cr 7.87TCr 7.7TCr 3,30000Cr |
| Date | Price | Change |
|---|---|---|
| 22/26/22 | $102.98 | +0.43% |
| 18/26/18 | $102.53 | +0.28% |
| 17/26/17 | $102.24 | -0.12% |
| 16/26/16 | $102.36 | +0.35% |
| 15/26/15 | $102.00 | -1.08% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
